
Egyban 150mg Tablet
Marketer
United Biotech Pvt Ltd
Salt Composition
Ibandronic Acid (150mg)
Overview Egyban 150mg Tablet
Osteoclast activity inhibition, achieved with 150mg Egyban tablets, addresses postmenopausal osteoporosis. This medication strengthens bones, reducing fracture risk in postmenopausal women with osteoporosis. Optimal absorption occurs when taken without food, consistently at evenly spaced intervals as directed by your physician. Continuous use, even with improvement, is crucial for maximum efficacy; full benefits may take several days to manifest. Egyban 150mg is one component of a comprehensive treatment plan, often incorporating dietary changes, calcium, and vitamin supplementation. Common, typically mild and transient, side effects include headache, elevated cholesterol, dizziness, upper respiratory or urinary tract infections, musculoskeletal pain, indigestion, heartburn, and diarrhea. Persistent side effects warrant immediate medical consultation. Serious side effects, such as kidney impairment (especially with dehydration, diuretic use, or pre-existing kidney disease), hypocalcemia, or oral/jaw pain, necessitate urgent medical attention. Breastfeeding contraindicates use. Prior to initiation, inform your doctor of kidney issues, low calcium levels, and all other medications, including those for infections, cancer, or osteoporosis, as interactions may occur. Regular monitoring of kidney function and mineral levels is often necessary. Smoking cessation and alcohol moderation are recommended to enhance bone health and reduce fracture risk due to diminished bone mineral density.
Uses of Egyban 150mg Tablet
Managing and mitigating postmenopausal osteoporosis
Major Benefits of Egyban 150mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 150mg Egyban tablet whole; do not crush, chew, or break it. Administer on an empty stomach.
Common Side effects of Egyban 150mg Tablet:
- Headache
- Musculoskeletal (bone, muscle or joint) pain
- Heartburn
- Diarrhea
- Indigestion
- Dizziness
- Hypercholesterolemia (high cholesterol)
- Upper respiratory tract infection
- Urinary tract infection
How to use Egyban 150mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer the Egyban 150mg Tablet on an empty stomach.
How Egyban 150mg Tablet works:
Osteoclast activity is inhibited by Egyban 150mg, a bisphosphonate tablet. This reduced bone cell breakdown leads to stronger bones and a decreased fracture risk.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining alcohol and Egyban 150mg tablets. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Egyban 150mg Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against potential dangers prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Egyban 150mg Tablet while breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by taking a 150mg Egyban tablet.
KidneySAFE IF PRESCRIBED
Egyban 150mg tablets can be used by patients with kidney disease without requiring a dosage change. Nevertheless, its administration is contraindicated in individuals experiencing severe renal dysfunction.
LiverSAFE IF PRESCRIBED
The use of Egyban 150mg tablets in individuals with liver impairment is likely safe. Current evidence indicates dose modification may be unnecessary, but physician consultation is recommended.
What if you forget to take Egyban 150mg Tablet :
Omit any missed Egyban 150mg Tablet dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Egyban 150mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Bisphosphonate Analog |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
| Behavior Class | Bisphosphonates: Bone Resorption Inhibitors |
